CHICAGO, May 29 – Micromass and Bio-Rad Laboratories have entered a deal to sell their jointly developed proteomics platform to the European Molecular Biology Laboratory in Heidelberg, Germany, a Micromass spokesman said Tuesday.
The ProteomeWorks System, a platform of integrated technologies, includes Bio-Rad’s 2-D gel electrophoresis and liquid chromatography instruments and Micromass’ Maldi-TOF mass spectrometry instrument, as well as sample preparation kits and consumables, bioinformatics software, and image analysis tools.